Clot-buster may unclog lung drains and relieve breathlessness
NCT ID NCT06184321
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether alteplase, a drug that dissolves blood clots, can improve drainage of fluid around the lungs and reduce shortness of breath in people with cancer-related pleural effusion that is not draining well. About 30 participants will receive either alteplase or a placebo through a chest tube. The main goal is to check safety and see if the drug helps control symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A smartphone app may help young cancer survivors get fitter — a trial puts it to the test
- Texting your symptoms: a digital coach for cancer side effects?
- Can a Two-Step stem cell transplant tame Graft-Versus-Host disease?
- Faith and mindfulness join forces to heal black cancer survivors
- Sniffing away sickness: essential oils tested for chemo nausea
- Lab-Grown stem cells could speed immune recovery in blood cancer transplants